Literature DB >> 28389793

Location characteristics of early gastric cancer treated with endoscopic submucosal dissection.

Dae Hwan Kang1, Cheol Woong Choi2, Hyung Wook Kim1, Su Bum Park1, Su Jin Kim1, Hyeong Seok Nam1, Dae Gon Ryu1.   

Abstract

BACKGROUND AND STUDY AIMS: The timely detection of early gastric cancer (EGC) is important in performing endoscopic submucosal dissection (ESD). We attempted to determine the location characteristics of regions where EGC is frequently detected and analyzed the EGC characteristics associated with that location.
METHODS: We retrospectively reviewed the medical records of patients with EGC treated by ESD between November 2008 and August 2016. We retrospectively investigated and analyzed 647 EGC lesions.
RESULTS: The patients' mean age was 66.7 ± 10.8 years. The patient population was predominantly male (77.1%, 499/647). A well-to-moderately differentiated carcinoma was observed in 97.2% of patients. The common site of carcinoma occurrence was the lower part of the stomach (the antrum and lower third of body, 89.6%). Among the stomach hemispheres, the lesser curvature side was the most frequent site of EGC (43.9%). The posterior side of EGC was more frequent than anterior side of EGC (20.4 vs. 15.6%, respectively). Submucosal invasive EGC was more frequent in the mid-to-upper parts of stomach than lower part of stomach (odds ratio 1.919; confidence interval 1.014-3.623; p = 0.045).
CONCLUSIONS: Most EGCs that are resectable with ESD were found in the lower part and in the lesser curvature of the stomach. The submucosal invasive EGC was more frequent in the mid-to-upper part of stomach.

Entities:  

Keywords:  Early gastric cancer; Endoscopic submucosal dissection; Location

Mesh:

Year:  2017        PMID: 28389793     DOI: 10.1007/s00464-017-5534-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  Stretching Causes Extensive Changes of Gastric Submucosa: Is It Acceptable to Define 500 microm as the Safe Margin?

Authors:  Sanghoon Park; Hoon Jai Chun; Yong Dae Kwon; Bora Keum; Yeon Seok Seo; Yong Sik Kim; Yoon-Tae Jeen; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu; Ji Hye Lee; Yang-Seok Chae
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

3.  Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer.

Authors:  K Okada; J Fujisaki; T Yoshida; H Ishikawa; T Suganuma; A Kasuga; M Omae; M Kubota; A Ishiyama; T Hirasawa; A Chino; M Inamori; Y Yamamoto; N Yamamoto; T Tsuchida; Y Tamegai; A Nakajima; E Hoshino; M Igarashi
Journal:  Endoscopy       Date:  2012-01-23       Impact factor: 10.093

4.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

5.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

6.  Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications.

Authors:  Ji Yong Ahn; Hwoon-Yong Jung; Kee Don Choi; Ji Young Choi; Mi-Young Kim; Jeong Hoon Lee; Kwi-Sook Choi; Do Hoon Kim; Ho June Song; Gin Hyug Lee; Jin-Ho Kim; Young Soo Park
Journal:  Gastrointest Endosc       Date:  2011-07-13       Impact factor: 9.427

7.  Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Authors:  Hye Seong Ahn; Hyuk-Joon Lee; Seokyung Hahn; Woo-Ho Kim; Kuhn Uk Lee; Takeshi Sano; Stephen B Edge; Han-Kwang Yang
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

8.  Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.

Authors:  Ji Yeong An; Yong Hae Baik; Min Gew Choi; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

9.  Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study.

Authors:  Hyung-Ho Kim; Sang-Uk Han; Min-Chan Kim; Woo Jin Hyung; Wook Kim; Hyuk-Joon Lee; Seung Wan Ryu; Gyu Seok Cho; Kyo Young Song; Seong Yeob Ryu
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

10.  Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients.

Authors:  Oh Jeong; Young-Kyu Park
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

View more
  13 in total

1.  Exploring the possibility of endoscopic submucosal dissection for clinical submucosal invasive early gastric cancers.

Authors:  Hyun Deok Lee; Hyunsoo Chung; Sang Gyun Kim; Jung Kim; Jue Lie Kim; Eunwoo Lee; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2019-02-06       Impact factor: 4.584

2.  Morphologic pattern analysis of submucosal deformities identified by endoscopic ultrasonography for predicting the depth of invasion in early gastric cancer.

Authors:  Tae Young Kim; Nam Hee Yi; Jin Won Hwang; Ji Hyun Kim; Gwang Ha Kim; Mi Seon Kang
Journal:  Surg Endosc       Date:  2018-10-17       Impact factor: 4.584

3.  The Characteristics, Prognosis, and Risk Factors of Lymph Node Metastasis in Early Gastric Cancer.

Authors:  Xuan Li; Shiyu Liu; Jin Yan; Lei Peng; Meihong Chen; Jiajia Yang; Guoxin Zhang
Journal:  Gastroenterol Res Pract       Date:  2018-05-02       Impact factor: 2.260

4.  Resection of Mucosal and Submucosal Gastrointestinal Lesions and a Double Endoscope Experience.

Authors:  Şükrü Çolak; Bünyamin Gürbulak; Ekrem Çakar; Hasan Bektaş
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

5.  Clinicopathologic characteristics of early gastric cancer according to specific intragastric location.

Authors:  Kyungeun Kim; Younghye Cho; Jin Hee Sohn; Dong-Hoon Kim; In Gu Do; Hyun Joo Lee; Sung-Im Do; Sangjeong Ahn; Hyoun Wook Lee; Seoung Wan Chae
Journal:  BMC Gastroenterol       Date:  2019-02-08       Impact factor: 3.067

6.  Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia.

Authors:  Kidane Siele Embaye; Chao Zhang; Matiwos Araya Ghebrehiwet; Zhihao Wang; Fengdi Zhang; Liwei Liu; Shenghui Qin; Lingzhi Qin; Jun Wang; Xi Wang
Journal:  BMC Cancer       Date:  2021-01-22       Impact factor: 4.430

7.  Risk-Scoring System for Prediction of Non-Curative Endoscopic Submucosal Dissection Requiring Additional Gastrectomy in Patients with Early Gastric Cancer.

Authors:  Tae-Se Kim; Byung-Hoon Min; Kyoung-Mee Kim; Heejin Yoo; Kyunga Kim; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  J Gastric Cancer       Date:  2021-11-26       Impact factor: 3.720

8.  Clinicopathologic Characteristics of Patients with Gastric Superficial Neoplasia and Risk Factors for Multiple Lesions after Endoscopic Submucosal Dissection in a Western Country.

Authors:  Gisela Brito-Gonçalves; Diogo Libânio; Pedro Marcos; Inês Pita; Rui Castro; Inês Sá; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  GE Port J Gastroenterol       Date:  2019-09-03

9.  Preprocedural prediction of non-curative endoscopic submucosal dissection for early gastric cancer.

Authors:  Hyeong Seok Nam; Cheol Woong Choi; Su Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Dae Gon Ryu; Jung Sik Choi
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

Review 10.  Common Locations of Gastric Cancer: Review of Research from the Endoscopic Submucosal Dissection Era.

Authors:  Su Jin Kim; Cheol Woong Choi
Journal:  J Korean Med Sci       Date:  2019-09-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.